Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
about
D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein.RNA dimerization defect in a Rous sarcoma virus matrix mutant.Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membraneEndophilins interact with Moloney murine leukemia virus Gag and modulate virion productionNucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsTrio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayersEffect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMRA comparative analysis of viral matrix proteins using disorder predictors.Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequencesEfficient HIV-1 replication can occur in the absence of the viral matrix protein.The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesRole of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory actMolecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsGlobal rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly
P2860
Q24316178-4F4498C3-D3AA-461A-BF43-186F0C97938AQ24524289-1826BAB9-0298-4EF0-B729-9CCD92A59FC4Q24563708-78180CD0-B415-40F7-86DF-DC1CD30A920FQ24799654-B3225F7D-184A-4480-9E4A-3C53B5240F55Q27312753-E791190F-A911-43C5-BF88-6DD634C590E0Q27676343-E71160CB-800C-4A99-A685-C218AD1589F5Q28554716-C0AC4E57-2EDF-433B-9BFB-DA2833F3A450Q33378970-7C577F90-299E-4D41-938F-455C9FAE9D81Q33642818-262B0C12-9BE0-4334-B0F3-5B4973FCDEF1Q33780632-E49DC961-02AA-47F4-8640-13DA854A0E81Q33784101-F1381F10-CF80-4CDF-8937-E39D6A7EC628Q33800293-3F0D8DDB-2DE6-478B-BB0F-44FE72BC2231Q33813747-2B4893B4-55D9-4123-8F49-303FC9AB79CDQ33815050-07C337D0-5016-4037-A736-95606AC30D09Q33825216-4088682D-EF24-4C31-9091-5EAACD64371CQ33888825-302E7145-F2F4-4F12-8E3A-B7C074CD45D9Q34306883-693F47FB-23CB-41DF-9D2A-115A4163310FQ34742397-E23F816A-13AF-45D4-8DE5-249DE7C585DFQ34984031-43FE855F-3A16-4B33-8EB8-394D2C94BEC1Q35010983-79CEFD2D-042E-49E8-BD0F-283A14EFB44FQ35635272-7D5EC84E-8CB1-4DC2-87E5-B50451EB434BQ35826475-6445DC65-1A58-4BC6-B95A-86E8FACDE141Q36459268-E0E056D0-4553-44EF-8806-677E0A4C7DDCQ36484055-5A74D732-C209-49CE-A298-E88EC00AF8F1Q36526260-A36E3C49-7358-476A-ABD5-429B81323147Q37308716-DBB5C891-B659-4641-9672-834DE963A79DQ37415605-BF701369-9103-4507-898E-C73329EB02DAQ39549710-0F3A35F1-055F-4180-ABE6-D138DB2E43D1Q40058240-77C7297E-6BE3-41C5-9828-54A17167223CQ41047831-C2201B0E-FCEC-4E0F-A23F-03C9BDF6A140
P2860
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Structure-function studies of ...... us type 1 matrix protein, p17.
@ast
Structure-function studies of ...... us type 1 matrix protein, p17.
@en
type
label
Structure-function studies of ...... us type 1 matrix protein, p17.
@ast
Structure-function studies of ...... us type 1 matrix protein, p17.
@en
prefLabel
Structure-function studies of ...... us type 1 matrix protein, p17.
@ast
Structure-function studies of ...... us type 1 matrix protein, p17.
@en
P2093
P2860
P1433
P1476
Structure-function studies of ...... us type 1 matrix protein, p17.
@en
P2093
A J Kingsman
D J Hockley
P M Cannon
S M Kingsman
S Matthews
P2860
P304
P407
P577
1997-05-01T00:00:00Z